News
Microplastics larger than 20 µm appear to be routinely present in commercially available eye drops, according to research published in Cornea. The investigation employed the use of micro-Fourier ...
2d
Zacks Investment Research on MSNKRYS Begins Dosing With Gene Therapy in Rare Eye Disease, Stock UpShares of Krystal Biotech KRYS gained 3.9% yesterday after the company announced that it had dosed the first patient in a phase I/II study evaluating its eye drop KB801 for the treatment of ...
This is a developing news story. Please check back soon for updates. Alcon will acquire LumiThera, including its ...
Boehringer Ingelheim recently announced the start of the THULITE phase II clinical study ( NCT06962839 ). THULITE will ...
5don MSN
Health officials have urgently recalled over 11,000 eye drops due to fears over contamination that could cause blindness.
VisionCorps' annual fundraiser, Eye Drop, was held Friday in downtown Lancaster.The rappel event raises awareness and funding to support services for people who are blind or have low vision ...
Five different eye drop products that were sold between May 2023 and April 2025 were identified in a recall from manufacturer AvKARE.
The FDA and AvKare have reported a recall of eye care products, including drops and artificial tears, from BRS Analytical Service.
Researchers have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa.
The FDA and Alcon Laboratories recalled one lot of Systane Lubricant Eye Drops Ultra PF, Single Vials On-the-Go, 25 count over fungal contamination.
One lot of Systane Lubricant Eye Drops Ultra PF, manufactured by Alcon Laboratories, has been recalled due to fungal contamination, the FDA announced this week.
Systane eye drops were recalled earlier this week after the company discovered a fungal contamination in one of its products.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results